![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Wednesday, March 26, 2014 3:56:58 AM
Also, is the MIRROR trial a third avenue to the approval of MyoCell? Whichever gets here first type scenario? Or is it for a specific application, of the MyoCell product intended for each?
One line in the 10K for MIRROR and no other, non-PR, public information.
On that note, I still have not heard back from clinicaltrials.gov regarding the MIRROR, as such a reason why I would like to see it published to have more public information as to the trial objectives and progress.
Final thought, if these are so far along, why start trials in other unrelated areas? Is it because they're in Phase I and easier to complete? Cost wise, resource wise?
Or is it that the company has encountered a more significant barrier pursuing their original objective in MARVEL, REGEN, and MIRROR trials?
I understand the financial nature of this early phase development biotech, so we're investing in the future knowing knowing cash flow is through equity and debt funding against an "estimated" time line.
The key for me is how they're spending that money and time to progress their flagship offerings. These are some of the questions I'm currently thinking about as I try to navigate through all the distractions and come to a better informed decision point. Any thoughts?
FEATURED Element79 Gold Corp Provides Update on Nevada Portfolio • Aug 23, 2024 8:00 AM
PickleJar Unveils Latest Venue Managed Services Innovations in Upcoming Webinar • PKLE • Aug 23, 2024 1:11 PM
Maybacks Adds Award Winning Show to Its Lineup Discusses Maybacks Opportunity • AHRO • Aug 22, 2024 11:30 AM
North Bay Resources Announces First Gold Concentrate at Mt. Vernon Gold Mine, Assays 12 oz/ton Gold, 17.5 oz/ton Platinum, and 8 oz./ton Silver, Sierra County, California • NBRI • Aug 22, 2024 10:28 AM
All Things Mobile Analytic, Inc. Reports Major Growth with Over $11 Million in Revenue • ATMH • Aug 22, 2024 7:19 AM
Unitronix Announces Strategic Entry into Cryptocurrency Space • UTRX • Aug 21, 2024 10:00 AM